The pharmaceutical landscape is seeing a shift with the emergence of GLP-1 transdermal systems . These exciting formulations offer a possible alternative to providing glucagon-like peptide-1 therapies for https://rishioarc662947.techionblog.com/41191187/glp-1-patches-a-novel-way-to-control-blood-sugar